Tag: Novartis Oncology
2021 Monica Warner Award: Call for Nominations
Advanced Accelerator Applications (AAA), a Novartis company, has announced that nominations are open for the 12th Annual Monica Warner Award! AAA is continuing the Novartis tradition of sponsoring the award, which commemorates the life and work …
READ MORE
New Guide on High-Grade Neuroendocrine Cancers
Have you or a loved one been diagnosed with high-grade neuroendocrine cancer? There’s a new guide for patients and caregivers, just released by the Healing NET Foundation in observance of NET Cancer Awareness Day, November 10, 2021. Healing NET worked…
READ MORE
Lisa Yen Selected as 2020 Monica Warner Award Recipient
Congratulations to Lisa Yen, NP, NBC-HWC, of LACNETS upon being selected as the 2020 Monica Warner Award recipient! The award, established by Novartis Oncology in 2009, is presented annually to “honor a patient, supporter, or caregiver who most embodies…
READ MORE
2020 Monica Warner Award: Call for Nominations
Advanced Accelerator Applications (AAA), a Novartis company, has announced that nominations are open for the 11th Annual Monica Warner Award! AAA is continuing the Novartis tradition of sponsoring the award, which commemorates the life and work of…
READ MORE
8th Annual Warner Advocacy Award: Call for Nominations
Novartis Oncology and The NET Alliance have announced that nominations are open for the 8th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize …
READ MORE Call for Nominations: 7th Annual Warner Advocacy Award
Novartis Oncology and The NET Alliance have announced that nominations are open for the 7th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize the …
READ MORE
Call for Nominations: 6th Annual Warner Advocacy Award
Do you know someone who is a passionate advocate for patients with neuroendocrine tumors (NETs)? Novartis Oncology and The NET Alliance are searching for an outstanding NET patient advocate to recognize and honor with the 6th Annual Warner Advocacy …
READ MORE
10 Highlights of the Year 2014 for the Carcinoid and Neuroendocrine Tumor Community
As the Carcinoid Cancer Foundation looks back on the year 2014, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…
READ MORE
Call for Nominations: 2014 Warner Advocacy Award
Do you know someone who is a passionate advocate for patients with neuroendocrine tumors (NETs)? The NET Alliance™ and Novartis Oncology have announced the 2014 Warner Advocacy Award, named in honor of the late Monica Warner, a driving force behind the…
READ MORE
Novartis Offers New Sandostatin LAR Depot Co-Pay Assistance Program
A new co-pay assistance program for carcinoid syndrome patients taking Sandostatin® LAR Depot has been established by Novartis Pharmaceuticals Corporation, effective February 2014.
With the Sandostatin® LAR Depot Co-Pay Assistance Program, eligible…
READ MORE